[What drug strategies are advisable for patients with advanced-stage Parkinson's]

Rev Neurol (Paris). 2000:156 Suppl 2 Pt 2:120-59.
[Article in French]
No abstract available

Publication types

  • Review

MeSH terms

  • Age Factors
  • Aged
  • Antiparkinson Agents / therapeutic use*
  • Disease Progression
  • Drug Therapy, Combination
  • Humans
  • Levodopa / therapeutic use
  • Parkinson Disease / drug therapy*
  • Parkinson Disease / physiopathology

Substances

  • Antiparkinson Agents
  • Levodopa